Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers September 22, 2018
Pharmacy Choice - News - Drug Delivery Systems - September 22, 2018

Pharmacy News

 Drug Delivery Systems
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 98     Next >>     Go To Page:

9/22/18 - Bayer's Jivi Approved in Japan for Hemophilia a
Bayer, a pharmaceutical and life sciences company, issued the following news release:. Bayer announced today that the Japanese Ministry of Health, Labour and Welfare has approved Jivi (R) for the prophylactic treatment of hemophilia A for adults and adolescents 12 years of age or older in Japan. Teruhisa Fujii, director of the Blood Transfusion Div
9/22/18 - Denmark-copenhagen: Pharmaceutical Products [TendersInfo (India)]
Contract notice: Denmark- Copenhagen: Pharmaceutical products. The tender number includes the following medicines: Tender no: 1, Atc code: L04ab05, Generic name: Certolizumab pegol, Dispensing form: Injection, Strength: 200 mg, Packing: Syringe/ pen, Unit value: 14 mg, Quantity in units: 211 668. Reference is made to the terms of the tender terms.
9/22/18 - Pulmonary Drug Delivery Devices Market to Surpass US$ 46,000 Mn and 1,676.0 Mn Units by 2026
Albany, NY 09/21/2018 Transparency Market Research has published a new report titled, "Pulmonary Drug Delivery Devices Market- Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018 2026". North America and Europe are expected to dominate the global pulmonary drug delivery devices market in the next few years. Additional
9/22/18 - Supply of Medical Devices (Automatic Dispensers of Syringe Medicines), Commissioning of Medical Devices, Training in the Rules for the Operation of Specialists Operating Medical Devices.
Company: COMPETITIVE AGENCY OF KALININGRAD REGION. Address: Russian Federation, 236007, Kaliningrad region, Kaliningrad, UL D.DONSKOGO, HOUSE 1 Attn: Pisochnyuk Anna Alexandrovna Tel: 8-4012-599399 Fax: 8-4012-599028. The initial contract price: 300000.00 Russian Ruble Date and time of the deadline for submission of applications: 03.10. 2018 11:00.
9/21/18 - Buprinorphine Transdermal Patch - 20 Mcg / Hour [TendersInfo (India)]
Tenders are invited for Buprinorphine transdermal patch- 20 mcg/ hour. Eligibility Criteria:- Major organization: CENTRAL RAILWAY Address: 2 Nd Floor, New Administrative Building, DN Road, Mumbai, Maharashtra Country: India Tender notice number: CRS192020008215 Notice type: Tender Notice Open date: 2018-10-05. Tender documents: T438118855.html, 438
9/21/18 - CHMP Recommends Approval of Buvidal (CAM2038) for the Treatment of Opioid Dependence
Camurus announced today that the European Medicines Agency's Committee for Medicinal Products for Human Use, CHMP, has adopted a positive opinion recommending approval of Buvidal prolonged-release solution for injection for treatment of opioid dependence in adults and adolescents from 16 years of age. "The excellent news that the CHMP recomme
9/21/18 - Data from Homi Bhabha National Institute Provide New Insights into Drug Delivery Systems (Photophysical and protolytic properties of neutral red with...
By a News Reporter-Staff News Editor at Drug Week A new study on Drugs and Therapies- Drug Delivery Systems is now available. According to news reporting from Maharashtra, India, by NewsRx journalists, research stated, "Stimuli-responsive supramolecular assemblies of potential drug/guest molecules through non-covalent host-guest interaction have.
9/21/18 - Exelixis' Partner Ipsen Announces Health Canada's Approval of CABOMETYX Tablets for the Treatment of Adults with Previously Treated Advanced Renal Cell Carcinoma
ALAMEDA- Exelixis, Inc. today announced that its partner Ipsen Biopharmaceuticals Canada Inc. received approval from Health Canada of CABOMETYX tablets for the treatment of adults with advanced renal cell carcinoma who have received prior vascular endothelial growth factor targeted therapy. 'The approval of CABOMETYX in Canada helps address a...
9/21/18 - Exelixis Partner Ipsen Announces Positive CHMP Opinion for CABOMETYX (cabozantinib) Tablets for Previously Treated Hepatocellular Carcinoma
Exelixis, Inc. today announced that its partner Ipsen received a positive opinion from the Committee for Medicinal Products for Human Use, the scientific committee of the European Medicines Agency, for CABOMETYX tablets as a monotherapy for the treatment of hepatocellular carcinoma in adults who have been previously treated with sorafenib.
9/21/18 - Global Intranasal Drug Delivery Market Forecast to 2025: BD, AptarGroup, 3M, Teleflex, HT Presspart, Bespak
Albany, NY 09/21/2018 This report studies the global market size of Intranasal Drug Delivery in key regions like North America, Europe, Asia Pacific, Central& South America and Middle East& Africa, focuses on the consumption of Intranasal Drug Delivery in these regions. This research report categorizes the global Intranasal Drug Delivery mark
9/21/18 - Global Nanotechnology Drug Delivery Market Growth Trends and Drivers Analysis 2018-2025
This report focuses on the global Nanotechnology Drug Delivery status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Nanotechnology Drug Delivery development in United States, Europe and Chin...
9/21/18 - Hot TLRY Cooling Off, ITRM On Watch, OMED To Report Phase Ib Data In Oct.
On September 20, IntelGenx signed a Letter of Intent with Tilray to enter into a world-wide agreement to produce cannabis-infused VersaFilm products. On Sep.18, the U.S. Drug Enforcement Administration approved the import of a pharmaceutical-grade medical cannabis product produced by Tilray into the United States for a clinical trial focused on...
9/21/18 - Investigators at Research Institute for Complex Issues of Cardiovascular Diseases Release New Data on Ischemia (Size-Dependent Ability of Liposomes...
By a News Reporter-Staff News Editor at Drug Week Researchers detail new data in Vascular Diseases and Conditions- Ischemia. According to news reporting from Kemerovo, Russia, by NewsRx journalists, research stated, "Liposomes have the potential to be used for drug delivery. The news correspondents obtained a quote from the research from the Rese
9/21/18 - Lipid-Based Drug Delivery in Modern Pharmaceutical Development to be Presented by Catalent and BASF at Forthcoming Workshop [Sport360]
-Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that it will be co-hosting a workshop with BASF Corporation entitled Revolutionary Then, Relevant Today: Lipid-Based Drug Delivery in Modern Pharmaceutical Development
9/21/18 - Lipid-Based Drug Delivery Presented by Catalent and BASF
SOMERSET, N.J.- Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that it will be co-hosting a workshop with BASF Corporation entitled "Revolutionary Then, Relevant Today: Lipid-Based Drug Delivery in Modern Pharmace
9/21/18 - Nanotechnology Drug Delivery Market 2018 - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2025
This report covers market characteristics, size and growth, segmentation, regional breakdowns, competitive landscape, market shares, trends and strategies. This report focuses on the global Nanotechnology Drug Delivery status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Nanotechnology Dru
9/21/18 - Nasal Drug Delivery Technology Market - Key growth strategies adopted by the top companies
The leading players in the Nasal Drug Delivery Technology Market include Merck & Co., Inc. (U.S.), Novartis AG (Switzerland), Johnson & Johnson Services, Inc. (U.S.), Pfizer, Inc. (U.S.), AstraZeneca plc. (U.S.), AptarGroup (U.S.), an...
9/21/18 - New Findings from Ohio State University Describe Advances in Drug Delivery Systems (Long Circulating Polymeric Nanoparticles for Gene/Drug Delivery)
By a News Reporter-Staff News Editor at Drug Week Research findings on Drugs and Therapies- Drug Delivery Systems are discussed in a new report. According to news originating from Columbus, Ohio, by NewsRx correspondents, research stated, "The prolonged circulation time of nanoparticles in the blood is a prerequisite to realize a controlled and t
9/21/18 - New Findings from Sardar Vallabhbhai National Institute of Technology in the Area of Drug Delivery Systems Reported (Nano-Vehicles for Drug Delivery...
New Findings from Sardar Vallabhbhai National Institute of Technology in the Area of Drug Delivery Systems Reported. Funders for this research include Department of Science and Technology, Institute Research Grants, Council of Scientific and Industrial Research, American Clinical Neurophysiology Society, Australian Nuclear Science and Technology...
9/21/18 - Otsuka Pharmaceutical Factory files patent infringement lawsuit against AY Pharmaceuticals and Yoshindo
Otsuka Pharmaceutical Factory, Inc. announced that it has filed a patent infringement lawsuit against AY Pharmaceuticals Co., Ltd. and Yoshindo Inc. in Tokyo District Court on September 19, 2018, alleging that ONEPAL No. 1 Injection and ONEPAL No. 2 Injection manufactured and distributed by AY Pharmaceuticals and distributed by Yoshindo infringe OP
9/21/18 - Patent Application Titled "Pharmaceutical Combination" Published Online (USPTO 20180243308)
By a News Reporter-Staff News Editor at Angiogenesis Weekly According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application by the inventors STEFANIC, Martin Friedrich; HILBERG, Frank; KAISER, Rolf; SHAPIRO, David, filed on May 1, 2018, was made available online on August 30, 2018. The assignee for this
9/21/18 - Pulmonary Drug Delivery Devices Market to Reach Value of Approximately US$28.7 Bn by 2019-End
Albany, NY 09/20/2018 Pulmonary drug delivery systems refer to the technologies that are used to treat diseases such as asthma, chronic obstructive pulmonary disease, and cystic fibrosis using pulmonary route of drug administration. However, the vendors of this market are expected to gain vast new opportunities in the emerging economies of As
9/21/18 - Recent Research from Hong Kong Polytechnic University Highlight Findings in Drug Delivery Systems (Effects of Compositional Tailoring on Drug...
Recent Research from Hong Kong Polytechnic University Highlight Findings in Drug Delivery Systems. According to news reporting out of Hong Kong, People's Republic of China, by NewsRx editors, research stated, "Conventional core- shell polymer nanoparticles usually exhibit a rapid release rate with their release kinetics mainly adjusted through chan
9/21/18 - Report Summarizes Drug Delivery Systems Study Findings from Medical College of Wisconsin [Engineering of "critical nanoscale design parameters"...
Report Summarizes Drug Delivery Systems Study Findings from Medical College of Wisconsin. According to news reporting out of Milwaukee, Wisconsin, by NewsRx editors, research stated, "Dendrimers are widely recognized as members of the fourth major architectural class of polymers after linear, cross-linked, and branched architectural types.
9/21/18 - Reports from University of Glasgow Provide New Insights into Drug Delivery Systems (Surface-Functionalization of Zr-Fumarate MOF for Selective...
Reports from University of Glasgow Provide New Insights into Drug Delivery Systems. Financial supporters for this research include Royal Society, University of Glasgow, H2020 European Research Council. The news correspondents obtained a quote from the research from the University of Glasgow, "In contrast, the isoreticular analog linked by fumarate
Articles(s): 1 - 25 of 98     Next >>     Go To Page:


© 2018 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2018 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415